UNSPSC 51384101: Fenbufen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9815R1WR9B, chemically known as propionic acid, 3-(4-biphenylylcarbonyl)- but generally known as fenbufen, which bears US NIH Compound Identifier 3335. European Medicines Agency schedules Fenbufen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07543MIG. The term FENBUFEN is an International Non-Proprietary Name.

UNSPSC 51384101 Fenbufen is a Commodity code for a specific anti-inflammatory pharmaceutical product; however, recent state and local procurement activity under this code shows no alignment with fenbufen procurement. Instead, Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 seeking to procure naloxone and drug deactivation systems—opioid-overdose reversal agents and controlled-substance disposal equipment—which fall outside fenbufen's pharmaceutical scope. The single recent opportunity identified under this code represents a clear mismatch between the UNSPSC taxonomy assignment and the goods actually being solicited, suggesting either a cataloging error in the state procurement system or minimal genuine fenbufen procurement activity at the state and local level.

Seminole County's naloxone and drug-deactivation-systems solicitation, with a response deadline of July 26, 2023, called for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract structure included a two-year initial term with a one-year renewal option, fixed-fee pricing, and standard compliance requirements including E-Verify authorization and workers' compensation insurance. The absence of additional recent opportunities under the fenbufen commodity code across other Florida counties, other states, or other issuing-body types indicates minimal current procurement activity that aligns with the code's actual pharmaceutical scope. Business development professionals should verify the correct UNSPSC code assignment before committing resources to this category.